← Back to patent-cliff list
CAS 10017-11-5
prop-2-en-1-amine hydrochloride
Codes: SEVE-008
Application context (from source-drug indications)
HyperphosphataemiaSevelamer CarbonateChronic renal impairmentSevelamer CarbonateNephropathySevelamer CarbonateEnd-stage renal diseaseSevelamer CarbonateRenal impairmentSevelamer CarbonateHyperparathyroidismSevelamer Carbonate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Sevelamer Carbonate | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-methylbutan-1-amine hydrochloride(1:x)→5-((3-((4-(aminomethyl)-2-methylhexyl)amino)-2-hydroxypropyl)amino)-2-ethyl-4-methylpentan-1-aminium chloride→prop-2-en-1-amine hydrochloride→1,3-dichloropropan-2-ol
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.